KR920011486A - 항종양제 - Google Patents

항종양제 Download PDF

Info

Publication number
KR920011486A
KR920011486A KR1019900019899A KR900019899A KR920011486A KR 920011486 A KR920011486 A KR 920011486A KR 1019900019899 A KR1019900019899 A KR 1019900019899A KR 900019899 A KR900019899 A KR 900019899A KR 920011486 A KR920011486 A KR 920011486A
Authority
KR
South Korea
Prior art keywords
acidic
quaternary salt
composition
methylenedioxybenzo
phenanthridinium
Prior art date
Application number
KR1019900019899A
Other languages
English (en)
Other versions
KR0159934B1 (ko
Inventor
미요지 하나오까
히사오 에끼모도
후미꼬 고바야시
유끼오 이리에
가쓰도시 다까하시
Original Assignee
원본미기재
닛뽕 덴소오 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 닛뽕 덴소오 가부시기가이샤 filed Critical 원본미기재
Publication of KR920011486A publication Critical patent/KR920011486A/ko
Application granted granted Critical
Publication of KR0159934B1 publication Critical patent/KR0159934B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

항종양제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 하기 구조식(A)의 7-히드록시-8-메톡시-5-메틸-2, 3-메틸렌디옥시벤조[C] 페난트리디늄 산성 4차염을 유효성분으로 함유하고 약제학적으로 허용되는 첨가제를 함유한 약제학적 조성물.
    (위의 식에서 X-는 산어성의 잔기이다.)
  2. 제1항에 있어서 산성 4차염이 할로게노산염인 조성물.
  3. 제1항에 있어서 산성 4차염이 염산염인 조성물.
  4. 제1항에 있어서 온혈동물의 악성종양의 성장억제, 전이억제 및 치료용 조성물.
  5. 악성종양의 치료, 성장억제 및 전이억제용 약제학적 조성물 제조를 위한 하기 구조식 (A)의 화합물의 용도.
    (위의 식에서 X-는 산성의 잔기이다)
  6. 의약용의 하기 구조식(A)의 7-히드록시-8-메톡시-5-메틸-2, 3-메틸렌디옥시벤조(C) 페난트리디늄산성 4차염
    (위의 식에서 X-는 산성의 잔기이다)
  7. 하기 구조식(A)의 7-히드록시-8-메톡시-5-메틸-2, 3-메틸렌디옥시벤조[C] 페난트리디늄 산성 4차염 유효투여량을 온혈동물에게 투여하여서 되는 종양이 있는 온혈동물의 종양의 성장억제, 전이억제 및 종양치료 방법.
    (위의 식에서 X-는 산성의 잔기이다)
  8. 제7항에 있어서 산성 4차염이 할로게노산염인 방법.
  9. 제7항에 있어서 산성 4차염이 염산염인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900019899A 1989-12-13 1990-12-05 항종양제 KR0159934B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-321503 1989-12-13
JP1321503A JP2528370B2 (ja) 1989-12-13 1989-12-13 抗腫瘍剤
JP01-321503 1989-12-13

Publications (2)

Publication Number Publication Date
KR920011486A true KR920011486A (ko) 1992-07-24
KR0159934B1 KR0159934B1 (ko) 1998-12-01

Family

ID=18133292

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900019899A KR0159934B1 (ko) 1989-12-13 1990-12-05 항종양제

Country Status (6)

Country Link
EP (1) EP0432630B1 (ko)
JP (1) JP2528370B2 (ko)
KR (1) KR0159934B1 (ko)
AU (1) AU629436B2 (ko)
CA (1) CA2032092A1 (ko)
DE (1) DE69007439T2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2054569A1 (en) * 1990-11-07 1992-05-08 Masanobu Suzuki Process for preparing benzo¬c|phenanthridinium derivatives, and novel compounds prepared by said process
TW460464B (en) * 1996-11-25 2001-10-21 Nippon Kayaku Kk Novel phenanthridinium derivative having an anti-tumor activity and pharmaceutical composition containing the same
EP2968279A4 (en) * 2013-03-15 2016-09-28 Lixte Biotechnology Inc SANGUINARIN ANALOG PPC2 HEMMER FOR CANCER TREATMENT

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767626A (en) * 1985-03-11 1988-08-30 Theodore Cheng Remedy for anemia and arthritis

Also Published As

Publication number Publication date
EP0432630B1 (en) 1994-03-16
DE69007439D1 (de) 1994-04-21
CA2032092A1 (en) 1991-06-14
KR0159934B1 (ko) 1998-12-01
JP2528370B2 (ja) 1996-08-28
EP0432630A3 (en) 1991-11-21
DE69007439T2 (de) 1994-07-14
JPH03184916A (ja) 1991-08-12
EP0432630A2 (en) 1991-06-19
AU629436B2 (en) 1992-10-01
AU6794590A (en) 1991-06-20

Similar Documents

Publication Publication Date Title
KR880001591A (ko) 테트라하이드로 나프탈렌 및 인단유도체
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
MY102980A (en) Transdermal flux enhancing compositions
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
KR890003691A (ko) 피페리딘 유도체 및 그를 함유하는 부정맥을 위한 치료예방제
KR900014406A (ko) 세펨 화합물 및 이의 제조방법
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
KR900001715A (ko) Bu-3608 유도체
KR920004387A (ko) 진통제 및 피부질환 치료용 국소용 소염제로서의 4-치환된 디하이드로피리도[4,3-d]피리미딘
EP0210753A3 (en) Anti-tumor medicament
KR920011486A (ko) 항종양제
OA07029A (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux.
KR927002224A (ko) 항종양효과증강제 및 항종양제
KR900014397A (ko) 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR880004810A (ko) 소화성 궤양 치료제
KR870006035A (ko) 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
EP0228314A3 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
RU99118510A (ru) Композиция для лечения или предупреждения рака простаты
IE39679L (en) Methods and compositions for killing parasites of warm¹blooded animals
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
RU98122110A (ru) Пиридил- и пиримидил-пиперазины в лечении болезней, вызываемых злоупотреблением лекарственными и/или наркотическими веществами
KR950008502A (ko) 3-또는4-클리코실옥시벤조피란 유도체 및 활성 성분으로서 이를 함유하는 알러지치료제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee